Skip to Main ContentSkip to FooterSkip to Search
Contact Us
Contact Us
Main menu
  1. Home
    2.  » Nottingham

Struggling with Poor Solubility, Bioavailability, or CMC Hurdles?

Get Expert Guidance from Catalent Nottingham Early Phase Development Team!

When solubility, bioavailability, or CMC setbacks threaten your timeline, Catalent Nottingham steps in with proven early-phase expertise, so you can move forward with confidence.

Book your free 1:1 Molecule Developability Assessment consultation, valued at £3,000

Our senior expert advisors will assess your molecule and map a smarter route to clinic, tailored to your goals and timeline using our proven methodology:

Limited availability. Secure your preferred consultation slot today.

Schedule My Free Consultation

Back to top

DON’T LET DEVELOPMENT BOTTLENECKS DERAIL YOUR PROGRAM

Behind every delay is a decision that could’ve gone better, with the right partner. Catalent Nottingham is the Early Phase Center of Excellence in Europe that leading innovators trust to:

  • Fix low solubility without sacrificing speed
  • Maximize bioavailability with minimal API
  • Navigate regulatory CMC requirements confidently
  • Formulate for pediatric and orphan drug success

Back to top

MEET YOUR ADVISORS

Get actionable insights from our senior team, trusted by global pharma innovators.

Stephen Tindal, Director, Scientific Advisory, Oral Small Molecules
Stephen helps drug developers uncover the root causes behind solubility, bioavailability, and CMC issues, and provides confirmation of the selected molecule and path, or alternates to consider (either for the primary indication or for future alternate indications).
Matt Ling, Ph.D., Director, Scientific Services
Matt assists drug developers in improving bioavailability and addressing delivery issues for poorly soluble compounds, including expertise in pediatric formulations.
Brigida Allieri, Ph.D., Technical Manager and Scientific Advisor
Brigida applies her expertise in material science to help drug developers enhance formulation stability and manufacturability and translates that insight into viable, phase-ready formulations
Start Your Consultation

Back to top

WHY CATALENT NOTTINGHAM

With over 20 years of experience and a fully integrated facility, we help you move faster with fewer hurdles.

  • MHRA- and FDA-approved GMP facility with full preclinical to small-scale commercial capabilities
  • OEB 1–3 and controlled drug license
  • Formulation development from simple to complex, including micronization, spray drying, HME, and analytical characterization
  • End-to-end support from PBPK modeling through Phase 1 clinical trial material, with integrated analytical services.
  • Phase 2, 3 and small-scale commercial manufacturing capabilities, with PBPK support.

Back to top

TRUSTED BY INNOVATORS ACROSS EUROPE

  • “Your PBPK work has saved this molecule that was practically killed”
  • “Your MDA has convinced us that you understand our needs and we will partner with you”
  • “Huge thanks to the Catalent Nottingham team… we have completed a huge volume of work over a short space of time, and we really appreciate all the hard work you have put in”
  • “Your team’s efforts on PBPK modeling has increased our confidence going in clinical studies”
  • “Catalent Nottingham helped us reduce risk in our Phase 1 formulation with rapid turnaround and deep scientific insight”

Back to top

BOOK YOUR CONSULTATION NOW

Complete the form below to connect with our expert advisors. We’ll reach out within 2 -3 business days to schedule your session.

  • (In-person / Virtual)